Charles river laboratories international inc CRL.US 總覽分析
)CRL 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分優異，但股利評分未超過2分，若公司開始配息，可能會有更優異的投資結果
CRL 近期報酬表現
0.83%
Charles river laboratories international inc
1.99%
同產業平均
-0.64%
S&P500
與 CRL 同產業的標的表現
- FTRE Fortrea holdings inc價值 -趨勢 2 分波段 4 分籌碼 2 分股利 1 分查看更多
CRL 公司資訊
Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.